www.allsides.com
Biden gives cannabis industry a badly needed win
The U.S. Drug Enforcement Agency is recommending that cannabis be reclassified as a Schedule III drug‚ which would codify that it has medicinal value and is less dangerous than its current Schedule I designation‚Â Axios has confirmed.
Why it matters:Â The U.S. cannabis industry needed a win‚ just days after one of its best-known companies‚ MedMen‚Â filed for bankruptcy protection.
Venture capital investment in cannabis companies has fallen sharply in the past couple of years‚...